Perspective

Reducing the infectious diseases burden through “life course approach vaccination” in India—a perspective

  • Received: 27 May 2021 Accepted: 01 August 2021 Published: 03 August 2021
  • The burden of vaccine-preventable diseases is increasing day by day across all age groups. However as per the universal immunization programme, we vaccinate only under-fives and antenatal mothers, a large portion of the vulnerable population remain unvaccinated and the concept of “life course approach” regarding vaccination is missing. It increases the overall burden to the already constrained Indian health care system. As India, now has become the largest manufacturer of multiple vaccines, we have continuous chain healthcare points (primary-tertiary level), with dedicated manpower in the public health sector that is why in this paper we are proposing to expand the horizon of the vaccination process using a “life course approach”. It will not only directly benefit the vulnerable populations (individual level), but also it can benefit the nation, indirectly. Although we may face challenges at multiple phases (conception to implementation), they can be overcome by multisectoral and multipronged innovations.

    Citation: Sheikh Mohd Saleem, Sudip Bhattacharya. Reducing the infectious diseases burden through “life course approach vaccination” in India—a perspective[J]. AIMS Public Health, 2021, 8(3): 553-562. doi: 10.3934/publichealth.2021045

    Related Papers:

  • The burden of vaccine-preventable diseases is increasing day by day across all age groups. However as per the universal immunization programme, we vaccinate only under-fives and antenatal mothers, a large portion of the vulnerable population remain unvaccinated and the concept of “life course approach” regarding vaccination is missing. It increases the overall burden to the already constrained Indian health care system. As India, now has become the largest manufacturer of multiple vaccines, we have continuous chain healthcare points (primary-tertiary level), with dedicated manpower in the public health sector that is why in this paper we are proposing to expand the horizon of the vaccination process using a “life course approach”. It will not only directly benefit the vulnerable populations (individual level), but also it can benefit the nation, indirectly. Although we may face challenges at multiple phases (conception to implementation), they can be overcome by multisectoral and multipronged innovations.



    加载中

    Acknowledgments



    The authors would like to thank all the authors of those books, articles, and journals that were referred in preparing this manuscript.

    Conflict of interest



    All authors declare no conflicts of interest in this paper.

    [1] Center of Desease Control and Prevention Immunization Basics Available from: https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm.
    [2] The History of Vaccines Timeline|The College of Physicians of Philadelphia (2018) .Available from: https://www.historyofvaccines.org/timeline/all.
    [3] Greenwood B (2014) The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci 369: 20130433. doi: 10.1098/rstb.2013.0433
    [4] VaccinesToday Life-course immunisation–future-proofing public health Available from: https://www.vaccinestoday.eu/stories/life-course-immunisation-future-proofing-public-health/.
    [5] Philip RK, Attwell K, Breuer T, et al. (2018) Life-course immunization as a gateway to health. Expert Rev Vaccines 17: 851-864. doi: 10.1080/14760584.2018.1527690
    [6] Worldometer World/Countries/India Available from: https://www.worldometers.info/coronavirus/country/india/.
    [7]  Scale up vaccination, ensure COVID-appropriate behaviour: J&K LG to DCs Available from: https://www.livemint.com/news/india/scale-up-vaccination-ensure-covid-appropriate-behaviour-j-k-lg-to-dcs-11618157018434.html.
    [8] Zepp F, Heininger U, Mertsola J, et al. (2011) Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 11: 557-570. doi: 10.1016/S1473-3099(11)70007-X
    [9] Loukov D, Naidoo A, Bowdish DM (2015) Immunosenescence: implications for vaccination programs in the elderly. Vaccine Develop Theory 5: 17-29.
    [10] Clar C, Oseni Z, Flowers N, et al. (2015) Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev 5: Cd005050.
    [11] Udell JA, Zawi R, Bhatt DL (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients. JAMA 310: 1711. doi: 10.1001/jama.2013.279206
    [12] Kirby J (2021) How Chile built one of the world's most successful vaccination campaigns-Vox Available from: https://www.vox.com/22309620/chile-covid-19-vaccination-campaign.
    [13] Clinical Health Care Radius (2021) Immunisation of adults' saves 2–3 million lives every year at large Available from: https://www.healthcareradius.in/clinical/28714-immunisation-of-adults-saves-2-3-million-lives-every-year-at-large.
    [14] Mereckiene J (2017) Technical Report: seasonal influenza vaccination in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons. 2007–2008 to 2014–2015. European Centre for Disease Prevention and Control (ECDC) Available from: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-vaccination-europe-vaccination-recommendations-and-coverage-2007-2015.
    [15] European Centre for Disease Prevention and Control Monthly measles and rubella monitoring report: August 2019 (2019) .Available from: https://www.ecdc.europa.eu/en/publications-data/monthly-measles-and-rubella-monitoring-report-august-2019.
    [16] Klugman KP, Black S (2018) Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects. Proc Natl Acad Sci USA 115: 12896-12901. doi: 10.1073/pnas.1721095115
    [17] Kwong JC, Maaten S, Upshur RE, et al. (2009) The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis 49: 750-756. doi: 10.1086/605087
    [18] Wiesen E, Diorditsa S, Li X (2016) Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990–2014. Vaccine 34: 2855-2862. doi: 10.1016/j.vaccine.2016.03.060
    [19] London School of Hygiene & Tropical Medicine HPV vaccination found to prevent more cases and deaths than previous estimates Available from: https://www.lshtm.ac.uk/newsevents/news/2021/hpv-vaccination-found-prevent-more-cases-and-deaths-previous-estimates.
    [20] Wateska AR, Nowalk MP, Zimmerman RK, et al. (2018) Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysis. BMC Infect Dis 18: 52. doi: 10.1186/s12879-018-2967-2
    [21] Vaccinate Your Family Vaccines are cost saving Available from: https://www.vaccinateyourfamily.org/why-vaccinate/vaccine-benefits/costs-of-disease-outbreaks/.
    [22] Whitney CG, Zhou F, Singleton J, et al. (2014) Benefits from immunization during the vaccines for children program era—United States, 1994–2013. MMWR Morb Mortal Wkly Rep 63: 352-355.
    [23] Ethgen O, Cornier M, Chriv E, et al. (2016) The cost of vaccination throughout life: a western European overview. Hum Vaccin Immunother 12: 2029-2037. doi: 10.1080/21645515.2016.1154649
    [24] National Health Mission: Immunization India Ministry of Health and Family Welfare (2020) .Available from: https://nhm.gov.in/index1.php?lang=1&level=2&sublinkid=824&lid=220.
    [25] Government of India Universal Immunisation Programme, National Health Portal of India (2018) .Available from: https://www.nhp.gov.in/universal-immunisation-programme_pg.
    [26] Lorber B (1988) Changing patterns of infectious diseases. Am J Med 84: 569-578. doi: 10.1016/0002-9343(88)90138-6
    [27] Paavonen J, Naud P, Salmerón J, et al. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314. doi: 10.1016/S0140-6736(09)61248-4
    [28] Bobdey S, Sathwara J, Jain A, et al. (2016) Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol 37: 278-285. doi: 10.4103/0971-5851.195751
    [29] Narayan VV, Iuliano AD, Roguski K, et al. (2020) Burden of influenza-associated respiratory and circulatory mortality in India, 2010–2013. J Glob Health 10: 010402. doi: 10.7189/jogh.10.010402
    [30] Murhekar MV, Kamaraj P, Kumar MS, et al. (2019) Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Heal 7: e1065-e1073. doi: 10.1016/S2214-109X(19)30250-5
    [31] Foppa IM, Cheng PY, Reynolds SB, et al. (2015) Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. Vaccine 33: 3003-3009. doi: 10.1016/j.vaccine.2015.02.042
    [32] Bhattacharya S, Gokdemir O, Bashar MA, et al. (2021) Is it the right time to introduce the hepatitis B booster vaccine in national immunization schedule? An analysis from the available evidence. Indian J Community Med 46: 4-6. doi: 10.4103/ijcm.IJCM_439_19
    [33] Tate J, Aguado T, Belie J, et al. (2019) The life-course approach to vaccination: Harnessing the benefits of vaccination throughout life. Vaccine 37: 6581-6583. doi: 10.1016/j.vaccine.2019.09.016
    [34] Sriram S (2018) Availability of infrastructure and manpower for primary health centers in a district in Andhra Pradesh, India. J Family Med Prim Care 7: 1256-1262. doi: 10.4103/jfmpc.jfmpc_194_18
    [35] CD Alert Adult Immunization (2011) .14: 1-8. Available from: https://ncdc.gov.in/WriteReadData/linkimages/February_Final_020862513827.pdf.
    [36] Association of Physicians of India (2020)  Adult Immunization in India: Changing the Immunization Paradigm Wiley India Publications, Available from: https://www.essentialknowledgebriefings.com/downloads/adult-immunization-in-india-changing-the-immunization-paradigm/.
    [37] Ozisik L, Tanriover MD, Rigby S, et al. (2016) ADVICE for a healthier life: Adult Vaccination Campaign in Europe. Eur J Intern Med 33: 14-20. doi: 10.1016/j.ejim.2016.04.021
    [38] Kimmel SR, Burns IT, Wolfe RM, et al. (2007) Addressing immunization barriers, benefits, and risks. J Fam Pract 56: S61-S69.
    [39] MacDougall DM, Halperin BA, MacKinnon-Cameron D, et al. (2015) The challenge of vaccinating adults: Attitudes and beliefs of the Canadian public and healthcare providers. BMJ Open 5: e009062. doi: 10.1136/bmjopen-2015-009062
    [40] Ozisik L, Calik Basaran N, Oz SG, et al. (2017) Perceptions and Attitudes of Patients About Adult Vaccination and Their Vaccination Status: Still a Long Way to Go? Med Sci Monit 23: 3178-3184. doi: 10.12659/MSM.901856
    [41] BMJ India's challenges with covid-19 vaccination Available from: https://blogs.bmj.com/bmj/2021/06/03/indias-challenges-with-covid-19-vaccination/.
    [42] Lahariya C, Bhardwaj P (2020) Adult vaccination in India: status and the way forward. Hum Vaccines Immunother 16: 1508-1510. doi: 10.1080/21645515.2019.1692564
    [43] World Health Organisation Ten threats to global health in 2019 (2019) .Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
    [44] Agrawal A, Kolhapure S, Di Pasquale A, et al. (2020) Vaccine Hesitancy as a Challenge or Vaccine Confidence as an Opportunity for Childhood Immunisation in India. Infect Dis Ther 9: 421-432. doi: 10.1007/s40121-020-00302-9
    [45] Gupta SK, Gupta P, Sharma P, et al. (2012) Emerging and Re-emerging Infectious Diseases, Future Challenges and Strategy. J Clincial Diagnostic Res 6: 1095-1100.
  • Reader Comments
  • © 2021 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2303) PDF downloads(134) Cited by(1)

Article outline

Figures and Tables

Tables(2)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog